Lalwani Nikhil's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Mar 8, 2024
- Accession no.
- 0001822629-24-000006
- Filed
- Mar 8, 2024
- Trade date
- Mar 6-8, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $2.99M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lalwani NikhilCIK 0001822629 | Director, Officer (PRESIDENT & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Common Stock | SSaleDisposed | −28,965 | $65.52F1 | −$1,897,786.8 | 444,981 | Direct | |
| Mar 7, 2024 | Common Stock | FTax withholdingDisposed | −17,060 | $66.71 | −$1,138,072.6 | 427,921 | Direct | |
| Mar 8, 2024 | Common Stock | SSaleDisposed | −16,292 | $67.13F3 | −$1,093,681.96 | 411,629 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were sold in multiple trades at prices ranging from $65.00 to $66.01. The price reported above reflects the weighted average sales price.
Referenced by the price of 1 transaction in Table I.
- F3
The shares were sold in multiple trades at prices ranging from $66.42 to $67.74. The price reported above reflects the weighted average sales price.
Referenced by the price of 1 transaction in Table I.